Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 123-126

  Kumagai, Atsushi ^a   Namba, Hiroyuki ^a   Mitsutake, Norisato ^a   Saenko, Vladimir A ^a   Ohtsuru, Akira ^b   Ito, Masahiro ^c   Noh, Jaeduk Yoshimura ^d   Sugino, Kiminori ^d   Ito, Koichi ^d   Yamashita, Shunichi ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d ITO HOSPITAL   (Japan)

Author keywords

BRAF; CD15; Mutation; Papillary thyroid carcinoma; Poorly differentiated thyroid tumor

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; CD15 ANTIGEN; DNA; PROTEIN P53; TP53 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CASE REPORT; CELL DIFFERENTIATION; CHILD; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; PAPILLARY CARCINOMA; PATHOLOGY; PHENOTYPE; THYROID TUMOR;

ANTIGENS, CD15; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CHILD; DNA; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750717833     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.123     Document Type: Article

References (22)

1. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE and Fagin JA: High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63: 1454-1457, 2003. (Pubitemid 36373628)
2. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T and Yamashita S: Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88: 4393-4397, 2003. (Pubitemid 37153748)
3. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA and Nikiforov YE: BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88: 5399-5404, 2003. (Pubitemid 37452745)
4. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW and Sidransky D: BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95: 625-627, 2003. (Pubitemid 36553510)
5. Xing M, Vasko V, Tallini G, Larin A, Wu G, Udelsman R, Ringel MD, Ladenson PW and Sidransky D: BRAFT1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab 89: 1365-1368, 2004. (Pubitemid 38368438)
6. Trovisco V, Vieira de Castro I, Soares P, Maximo V, Silva P, Magalhaes J, Abrosimov A, Guiu XM and Sobrinho-Simoes M: BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202: 247-251, 2004. (Pubitemid 38208663)
7. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D and Westra WH: Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 10: 2761-2765, 2004. (Pubitemid 38509152)
8. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D and Ladenson PW: Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89: 2867-2872, 2004. (Pubitemid 38766378)
9. Hayashida N, Namba H, Kumagai A, Hayashi T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T and Yamashita S: A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells. Thyroid 14: 910-915, 2004. (Pubitemid 39612909)
10. Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y and Yamashita S: Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4280-4284, 2004. (Pubitemid 39244426)
11. Lima J, Trovisco V, Soares P, Maximo V, Magalhaes J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D and Sobrinho-Simoes M: BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 89: 4267-4271, 2004. (Pubitemid 39244424)
12. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N and Akiyama M: Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52: 1369-1371, 1992.
13. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G and Pierotti MA: Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91: 1753-1760, 1993. (Pubitemid 23127381)
14. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH and Koeffler HP: High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91: 179-184, 1993. (Pubitemid 23037270)
15. Ain KB: Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8: 715-726, 1998.
16. Mai KT, Ford JC, Yazdi HM, Perkins DG and Commons AS: Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules. Pathol Res Pract 196: 533-540, 2000. (Pubitemid 30646764)
17. Kim KH, Kang DW, Kim SH, Seong IO and Kang DY: Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45: 818-821, 2004. (Pubitemid 39545368)
18. Vasko V, Hu S, Wu G, Xing JC, Larin A, Savchenko V, Trink B and Xing M: High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes. J Clin Endocrinol Metab 2005.
19. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D and Ladenson PW: BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90: 6373-6379, 2005. (Pubitemid 41759286)
20. Knauf JA, Ma X, Smith EP, Zhang L, Mitsutake N, Liao XH, Refetoff S, Nikiforov YE and Fagin JA: Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res 65: 4238-4245, 2005. (Pubitemid 40775662)
21. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S and Ledent C: Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378, 1996. (Pubitemid 26005013)
22. Mitsutake N, Knauf JA, Mitsutake S, Mesa C Jr, Zhang L and Fagin JA: Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 65: 2465-2473, 2005. (Pubitemid 40490159) Technology Technology